DEA to Increase Hydrocodone Combination Product Oversight

Yesterday, the Drug Enforcement Administration (DEA) announced that it will enforce stronger regulations for individuals who handle hydrocodone combination products (HCPs).  This rule will shift HCPs from Schedule III to Schedule II of the Controlled Substances Act -- the designation for products that are most subject to abuse and mishandling.  This rule will go into effect 45 days from DEA's official announcement.